| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K66532283 |
| PharmacoGx | BRD-K66532283 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PBRM1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | ADGRA2 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | UBE2K | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | TMEM237 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | TNFRSF17 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | PARD6G | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | ARMC1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | PCBP3 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | VANGL2 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | AP3D1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
